Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways

Chemoresistance due to heterogeneity of the tumor microenvironment (TME) hampers the long-term efficacy of frontline therapies for lung cancer. Current combination therapies for lung cancer provide only modest improvement in survival, implicating necessity for novel approaches that suppress malignan...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sawant, Anandi, Schafer, Cara C., Jin, Tong Huan, Zmijewski, Jaroslaw, Tse, Hubert M., Roth, Justin, Sun, Zhihuan, Siegal, Gene P., Thannickal, Victor J., Grant, Stefan C., Ponnazhagan, Selvarangan, Deshane, Jessy S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854493/
https://ncbi.nlm.nih.gov/pubmed/24085788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-0987
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares